Puzo Michael J reduced its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 0.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,262 shares of the company’s stock after selling 25 shares during the period. Puzo Michael J’s holdings in Colgate-Palmolive were worth $677,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. Chickasaw Capital Management LLC increased its position in Colgate-Palmolive by 218.3% during the 1st quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after buying an additional 11,605 shares in the last quarter. Meritage Portfolio Management increased its position in Colgate-Palmolive by 0.3% during the 1st quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after buying an additional 255 shares in the last quarter. Israel Discount Bank of New York acquired a new position in Colgate-Palmolive during the 1st quarter valued at about $1,349,000. ProShare Advisors LLC increased its position in Colgate-Palmolive by 9.9% during the 1st quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock valued at $64,382,000 after buying an additional 79,323 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in Colgate-Palmolive by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after buying an additional 7,905 shares in the last quarter. 73.16% of the stock is currently owned by institutional investors.
Several research analysts recently issued reports on CL shares. Bank of America Corporation upped their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research report on Tuesday, July 4th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. BidaskClub lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $76.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $75.82.
Colgate-Palmolive Company (NYSE CL) traded down 0.1033% during mid-day trading on Tuesday, reaching $71.9456. The company had a trading volume of 630,914 shares. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a market capitalization of $63.37 billion, a price-to-earnings ratio of 26.7356 and a beta of 0.80. The firm’s 50 day moving average price is $71.61 and its 200-day moving average price is $73.33.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same period in the previous year, the business earned $0.70 EPS. The business’s quarterly revenue was down .5% on a year-over-year basis. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
In related news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the transaction, the insider now owns 53,173 shares in the company, valued at approximately $3,799,210.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ellen M. Hancock sold 5,057 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $71.91, for a total value of $363,648.87. Following the completion of the transaction, the director now owns 199,777 shares in the company, valued at approximately $14,365,964.07. The disclosure for this sale can be found here. Insiders sold a total of 221,802 shares of company stock valued at $15,983,976 over the last three months. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.